From understanding microbiome functionality, leveraging lessons from clinical development and scaling manufacturing processes, through to utilizing microbiome biomarkers for patient stratification and diagnostics, these discussions will cover the latest scientific findings and industry updates from the end-to-end development of microbiome therapeutics.
The 6th Microbiome Movement – Drug Development Summit will provide the perfect opportunity for a collaborative approach to develop a new generation of microbiome-targeted therapeutics that improves patients lives.
